SMIP-7.7

N/A

Report date: 2024/11/05 16:33:32
NME

Base Information

Drug NameSMIP-7.7
Drug Alias NameSMIP-7.7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCincinnati Children'S Hospital Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCincinnati Children'S Hospital Medical Center
Active IndicationsN/A
Inactive IndicationsHerpes Simplex Virus Type 2 Infections

Other Information

ATC CodeN/A
Related LinksN/A